Global female infertility diagnosis and treatment market is anticipated to grow at a CAGR of 5.6% during the forecast period (2024-2031). The rising trends of surrogacy, the growing infertility rate among females, and new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing to the market growth. Advancement in IVF treatments has opened up new potential opportunities with positive results of IVF procedures. It is expected to propel the demand for female infertility diagnosis and treatment market during the forecasted period.
Get Free Sample link @ https://www.omrglobal.com/request-sample/female-infertility-market-size
Recent Developments in the Female Infertility Diagnosis and Treatment Market
- In February 2024, Catalent, Inc. and Novo Holdings, announced that they have entered into a merger agreement. Novo Holdings has acquired Catalent in an all-cash transaction, valuing Catalent at $16.5 billion. The acquisition is aimed at Novo Holdings’ mandate to invest in high-quality life sciences companies.
- In September 2023, Femasys Inc., a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage.
Full report of Female Infertility Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/female-infertility-market-size
Market Coverage
- The market number available for – 2023-2031
- Base year- 2023
- Forecast period- 2024-2031
- Segment Covered-
o By Diagnosis
o By Treatment
o By End User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- AbbVie Inc., Bayer AG, CooperSurgical Inc., Eli Lilly and Co., and Merck KGaA, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Female Infertility Diagnosis and Treatment Market Report Segment
By Diagnosis
- Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By End User
- Hospitals and Clinics
- Homecare
- Pathology
- Diagnostic Centers
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
